Skip to main content
Erschienen in: La radiologia medica 9/2016

01.09.2016 | CHEST RADIOLOGY

Resected pN1 non-small cell lung cancer: recurrence patterns and nodal risk factors may suggest selection criteria for post-operative radiotherapy

verfasst von: Paolo Borghetti, Fernando Barbera, Marco Lorenzo Bonù, Francesca Trevisan, Stefano Ciccarelli, Paola Vitali, Marta Maddalo, Luca Triggiani, Nadia Pasinetti, Sara Pedretti, Bartolomea Bonetti, Gianluca Pariscenti, Andrea Tironi, Alberto Caprioli, Michela Buglione, Stefano Maria Magrini

Erschienen in: La radiologia medica | Ausgabe 9/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To describe the pattern of recurrence in resected pN1 non-small cell lung cancer (NSCLC) and to identify factors predicting an increased risk of locoregional recurrence (LR) or distant metastasis (DM) to define a selected population who may benefit from postoperative radiotherapy (PORT).

Methods

285 patients with resected pN1 NSCLC were identified. Patients with positive surgical margins, undergoing neoadjuvant treatment or PORT, were excluded. LR was defined as first event of recurrence at the surgical bed, ipsilateral hilum or mediastinum, and other sites were considered as DM. Kaplan–Meier actuarial estimates of overall survival (OS), progression-free survival (PFS), freedom from LR (FFLR) and freedom from DM (FFDM) in different subgroups were compared with the log-rank test. Multivariate analysis was calculated.

Results

202 patients met the inclusion criteria, 24 % received adjuvant chemotherapy. The median follow-up was 39 months. The total number of recurrences was 118 (64.4 %): 44 (24 %) and 74 (40.4 %) for LR and DM, respectively. Five-year OS and PFS rates were 39.2 and 33.3 %, respectively. Extra capsular extension (ECE) (RR 2.10, p = 0.01) and lymph nodal ratio (LNR) >0:15 (RR 1.68, p = 0.015) were associated with a worse PFS. ECE and LNR >0.15 were significantly related to a worst FFLR (RR 3.04 and 4.42, respectively), and adenocarcinoma to an unfavorable FFDM (RR 1.97, p = 0.013).

Conclusions

Nodal factors as high LNR and ECE can predict an increased risk of worse FFLR and PFS. Prospective data on selected patients, treated with modern radiotherapy techniques, need to be collected to re-evaluate the role of radiotherapy.
Literatur
1.
Zurück zum Zitat Edge SB, Byrd DR, Compton CC et al (2010) AJCC cancer staging manual, 7th edn. Springer, Chicago Edge SB, Byrd DR, Compton CC et al (2010) AJCC cancer staging manual, 7th edn. Springer, Chicago
3.
Zurück zum Zitat Fan C, Gao S, Hui Z, Liang J, Lv J, Wang X et al (2013) Risk factors for locoregional recurrence in patients with resected N1 non-small cell lung cancer: a retrospective study to identify patterns of failure and implications for adjuvant radiotherapy. Radiat Oncol 8:286. doi:10.1186/1748-717X-8-286 CrossRefPubMedPubMedCentral Fan C, Gao S, Hui Z, Liang J, Lv J, Wang X et al (2013) Risk factors for locoregional recurrence in patients with resected N1 non-small cell lung cancer: a retrospective study to identify patterns of failure and implications for adjuvant radiotherapy. Radiat Oncol 8:286. doi:10.​1186/​1748-717X-8-286 CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat NSCLC Meta-analyses Collaborative Group, Arriagada R, Auperin A, Burdett S, Higgins JP, Johnson DH, Le Chevalier T, Le Pechoux C, Parmar MK, Pignon JP et al (2010) Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data. Lancet 375(9722):1267–1277. doi:10.1016/S0140-6736(10)60059-1 CrossRefPubMedCentral NSCLC Meta-analyses Collaborative Group, Arriagada R, Auperin A, Burdett S, Higgins JP, Johnson DH, Le Chevalier T, Le Pechoux C, Parmar MK, Pignon JP et al (2010) Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data. Lancet 375(9722):1267–1277. doi:10.​1016/​S0140-6736(10)60059-1 CrossRefPubMedCentral
5.
Zurück zum Zitat Alam N, Shepherd F, Winton T, Graham B, Johnson D, Livingston R et al (2005) Compliance with post-operative adjuvant chemotherapy in non-small cell lung cancer. an analysis of national cancer institute of canada and intergroup trial JBR.10 and a review of the literature. Lung Cancer 47(3):385–394. doi:10.1016/j.lungcan.2004.08.016 CrossRefPubMed Alam N, Shepherd F, Winton T, Graham B, Johnson D, Livingston R et al (2005) Compliance with post-operative adjuvant chemotherapy in non-small cell lung cancer. an analysis of national cancer institute of canada and intergroup trial JBR.10 and a review of the literature. Lung Cancer 47(3):385–394. doi:10.​1016/​j.​lungcan.​2004.​08.​016 CrossRefPubMed
6.
Zurück zum Zitat PORT meta-analysis trialists group (1998) Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trials. Lancet 352(9124):257–263. doi:10.1016/S0140-6736(98)06341-7 CrossRef PORT meta-analysis trialists group (1998) Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trials. Lancet 352(9124):257–263. doi:10.​1016/​S0140-6736(98)06341-7 CrossRef
8.
Zurück zum Zitat Varlotto J, Yao A, DeCamp M, Ramakrishna S, Recht A, Flickinger J et al (2015) Nodal stage of surgically resected non-small cell lung cancer and its effect on recurrence patterns and overall survival. Int J Radiat Oncol Biol Phys 91(4):765–773. doi:10.1016/j.ijrobp.2014.12.028 CrossRefPubMed Varlotto J, Yao A, DeCamp M, Ramakrishna S, Recht A, Flickinger J et al (2015) Nodal stage of surgically resected non-small cell lung cancer and its effect on recurrence patterns and overall survival. Int J Radiat Oncol Biol Phys 91(4):765–773. doi:10.​1016/​j.​ijrobp.​2014.​12.​028 CrossRefPubMed
9.
Zurück zum Zitat Lardinois D, Suter H, Hakki H, Rousson V, Betticher D, Ris H (2005) Morbidity, survival, and site of recurrence after mediastinal lymph-node dissection versus systematic sampling after complete resection for non-small cell lung cancer. Ann Thorac Surg 80(1):268–274. doi:10.1016/j.athoracsur.2005.02.005 CrossRefPubMed Lardinois D, Suter H, Hakki H, Rousson V, Betticher D, Ris H (2005) Morbidity, survival, and site of recurrence after mediastinal lymph-node dissection versus systematic sampling after complete resection for non-small cell lung cancer. Ann Thorac Surg 80(1):268–274. doi:10.​1016/​j.​athoracsur.​2005.​02.​005 CrossRefPubMed
11.
Zurück zum Zitat Douillard J, Rosell R, De Lena M, Riggi M, Hurteloup P, Mahe M (2008) Impact of postoperative radiation therapy on survival in patients with complete resection and stage I, II, or IIIA non-small-cell lung cancer treated with adjuvant chemotherapy: the adjuvant navelbine international trialist association (ANITA) randomized trial. Int J Radiat Oncol Biol Phys 72(3):695–701. doi:10.1016/j.ijrobp.2008.01.044 CrossRefPubMed Douillard J, Rosell R, De Lena M, Riggi M, Hurteloup P, Mahe M (2008) Impact of postoperative radiation therapy on survival in patients with complete resection and stage I, II, or IIIA non-small-cell lung cancer treated with adjuvant chemotherapy: the adjuvant navelbine international trialist association (ANITA) randomized trial. Int J Radiat Oncol Biol Phys 72(3):695–701. doi:10.​1016/​j.​ijrobp.​2008.​01.​044 CrossRefPubMed
12.
Zurück zum Zitat PORT Meta-analysis Trialists Group (2000) Postoperative radiotherapy for non-small cell lung cancer. Cochrane Database Syst Rev 2:CD002142. [(2003) Review. Update Cochrane Database Syst Rev 1:CD002142] PORT Meta-analysis Trialists Group (2000) Postoperative radiotherapy for non-small cell lung cancer. Cochrane Database Syst Rev 2:CD002142. [(2003) Review. Update Cochrane Database Syst Rev 1:CD002142]
13.
Zurück zum Zitat PORT Meta-Analysis Trialists Group (2003) Postoperative radiotherapy for non-small cell lung cancer. Cochrane Database Syst Rev.1:CD002142. [(2005) Review. Update Cochrane Database Syst Rev 2:CD002142] PORT Meta-Analysis Trialists Group (2003) Postoperative radiotherapy for non-small cell lung cancer. Cochrane Database Syst Rev.1:CD002142. [(2005) Review. Update Cochrane Database Syst Rev 2:CD002142]
14.
Zurück zum Zitat PORT Meta-analysis Trialists Group (2005) Postoperative radiotherapy for non-small cell lung cancer. Cochrane Database Syst Rev 2:CD002142 Review PORT Meta-analysis Trialists Group (2005) Postoperative radiotherapy for non-small cell lung cancer. Cochrane Database Syst Rev 2:CD002142 Review
15.
Zurück zum Zitat Billiet C, Decaluwé H, Peeters S, Vansteenkiste J, Dooms C, Haustermans K et al (2014) Modern post-operative radiotherapy for stage III non-small cell lung cancer may improve local control and survival: a meta-analysis. Radiother Oncol 110(1):3–8. doi:10.1016/j.radonc.2013.08.011 CrossRefPubMed Billiet C, Decaluwé H, Peeters S, Vansteenkiste J, Dooms C, Haustermans K et al (2014) Modern post-operative radiotherapy for stage III non-small cell lung cancer may improve local control and survival: a meta-analysis. Radiother Oncol 110(1):3–8. doi:10.​1016/​j.​radonc.​2013.​08.​011 CrossRefPubMed
16.
Zurück zum Zitat Kepka L, Bujko K, Orlowski T, Jagiello R, Salata A, Matecka Nowak M et al (2011) Cardiopulmonary morbidity and quality of life in non-small cell lung cancer patients treated with or without postoperative radiotherapy. Radiother Oncol 98(2):238–243. doi:10.1016/j.radonc.2010.09.020 CrossRefPubMed Kepka L, Bujko K, Orlowski T, Jagiello R, Salata A, Matecka Nowak M et al (2011) Cardiopulmonary morbidity and quality of life in non-small cell lung cancer patients treated with or without postoperative radiotherapy. Radiother Oncol 98(2):238–243. doi:10.​1016/​j.​radonc.​2010.​09.​020 CrossRefPubMed
17.
Zurück zum Zitat Vansteenkiste JF, De Leyn PR, Deneffe GJ, Stalpaert G, Nackaerts KL, Lerut TE et al (1997) Survival and prognostic factors in resected N2 non-small cell lung cancer: a study of 140 cases leuven lung cancer group. Ann Thorac Surg 63(5):1441–1450. doi:10.1016/S0003-4975(97)00314-7 CrossRefPubMed Vansteenkiste JF, De Leyn PR, Deneffe GJ, Stalpaert G, Nackaerts KL, Lerut TE et al (1997) Survival and prognostic factors in resected N2 non-small cell lung cancer: a study of 140 cases leuven lung cancer group. Ann Thorac Surg 63(5):1441–1450. doi:10.​1016/​S0003-4975(97)00314-7 CrossRefPubMed
18.
Zurück zum Zitat Bucci JA, Kennedy CW, Burn J, Gillett DJ, Carmalt HL, Donnellan MJ et al (2001) Implications of extranodal spread in node positive breast cancer: a review of survival and local recurrence. Breast 10(3):213–219. doi:10.1054/brst.2000.0233 CrossRefPubMed Bucci JA, Kennedy CW, Burn J, Gillett DJ, Carmalt HL, Donnellan MJ et al (2001) Implications of extranodal spread in node positive breast cancer: a review of survival and local recurrence. Breast 10(3):213–219. doi:10.​1054/​brst.​2000.​0233 CrossRefPubMed
19.
Zurück zum Zitat Carter RL, Bliss JM, Soo KC, O’Brien CJ (1987) Radical neck dissections for squamous carcinomas: pathological findings and their clinical implications with particular reference to transcapsular spread. Int J Radiat Oncol Biol Phys 13(6):825–832. doi:10.1016/0360-3016(87)90094-0 CrossRefPubMed Carter RL, Bliss JM, Soo KC, O’Brien CJ (1987) Radical neck dissections for squamous carcinomas: pathological findings and their clinical implications with particular reference to transcapsular spread. Int J Radiat Oncol Biol Phys 13(6):825–832. doi:10.​1016/​0360-3016(87)90094-0 CrossRefPubMed
22.
Zurück zum Zitat Ahn T, Kim H, Jeong C, Kwak C, Ku J (2015) Extracapsular extension of pelvic lymph node metastasis is an independent prognostic factor in bladder cancer: a systematic review and meta-analysis. Ann Surg Oncol 22(11):3745–3750. doi:10.1245/s10434-014-4359-1 CrossRefPubMed Ahn T, Kim H, Jeong C, Kwak C, Ku J (2015) Extracapsular extension of pelvic lymph node metastasis is an independent prognostic factor in bladder cancer: a systematic review and meta-analysis. Ann Surg Oncol 22(11):3745–3750. doi:10.​1245/​s10434-014-4359-1 CrossRefPubMed
25.
26.
28.
Zurück zum Zitat Turker I, Arslan U, Yazici O, Uyeturk U, Oksuzoglu B, Budakoglu B et al (2014) Prognostic factors in operated stage IIIC, pathological N3a breast cancer patients. Breast Care (Basel) 9(6):421–427. doi:10.1159/000366438 CrossRef Turker I, Arslan U, Yazici O, Uyeturk U, Oksuzoglu B, Budakoglu B et al (2014) Prognostic factors in operated stage IIIC, pathological N3a breast cancer patients. Breast Care (Basel) 9(6):421–427. doi:10.​1159/​000366438 CrossRef
31.
Zurück zum Zitat Kiriyama M, Ebata T, Aoba T, Kaneoka Y, Arai T, Shimizu Y et al (2015) Prognostic impact of lymph node metastasis in distal cholangiocarcinoma. Br J Surg 102(4):399–406. doi:10.1002/bjs.9752 CrossRefPubMed Kiriyama M, Ebata T, Aoba T, Kaneoka Y, Arai T, Shimizu Y et al (2015) Prognostic impact of lymph node metastasis in distal cholangiocarcinoma. Br J Surg 102(4):399–406. doi:10.​1002/​bjs.​9752 CrossRefPubMed
Metadaten
Titel
Resected pN1 non-small cell lung cancer: recurrence patterns and nodal risk factors may suggest selection criteria for post-operative radiotherapy
verfasst von
Paolo Borghetti
Fernando Barbera
Marco Lorenzo Bonù
Francesca Trevisan
Stefano Ciccarelli
Paola Vitali
Marta Maddalo
Luca Triggiani
Nadia Pasinetti
Sara Pedretti
Bartolomea Bonetti
Gianluca Pariscenti
Andrea Tironi
Alberto Caprioli
Michela Buglione
Stefano Maria Magrini
Publikationsdatum
01.09.2016
Verlag
Springer Milan
Erschienen in
La radiologia medica / Ausgabe 9/2016
Print ISSN: 0033-8362
Elektronische ISSN: 1826-6983
DOI
https://doi.org/10.1007/s11547-016-0648-z

Weitere Artikel der Ausgabe 9/2016

La radiologia medica 9/2016 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.